ZA201005905B - Methods,dosage forms,and kits for administering ziprasidone without food - Google Patents

Methods,dosage forms,and kits for administering ziprasidone without food

Info

Publication number
ZA201005905B
ZA201005905B ZA2010/05905A ZA201005905A ZA201005905B ZA 201005905 B ZA201005905 B ZA 201005905B ZA 2010/05905 A ZA2010/05905 A ZA 2010/05905A ZA 201005905 A ZA201005905 A ZA 201005905A ZA 201005905 B ZA201005905 B ZA 201005905B
Authority
ZA
South Africa
Prior art keywords
kits
food
methods
dosage forms
ziprasidone
Prior art date
Application number
ZA2010/05905A
Other languages
English (en)
Inventor
William John Curatolo
Scott Max Herbig
Avinash Govind Thombre
Jaymin Chandrakant Shah
Sheri L Shamblin
Timothy Michael Lukas
William Brett Caldwell
Dwayne Thomas Friesen
David Keith Lyon
Christopher Donovan Craig
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA201005905B publication Critical patent/ZA201005905B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2010/05905A 2008-03-07 2010-08-18 Methods,dosage forms,and kits for administering ziprasidone without food ZA201005905B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3494708P 2008-03-07 2008-03-07
PCT/IB2009/000442 WO2009109844A1 (en) 2008-03-07 2009-03-04 Methods, dosage forms, and kits for administering ziprasidone without food

Publications (1)

Publication Number Publication Date
ZA201005905B true ZA201005905B (en) 2011-11-30

Family

ID=40720011

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/05905A ZA201005905B (en) 2008-03-07 2010-08-18 Methods,dosage forms,and kits for administering ziprasidone without food

Country Status (15)

Country Link
US (1) US20110002989A1 (enExample)
EP (1) EP2280711A1 (enExample)
JP (1) JP2009215293A (enExample)
KR (1) KR20100131477A (enExample)
CN (1) CN102014910A (enExample)
AR (1) AR070964A1 (enExample)
AU (1) AU2009220925A1 (enExample)
BR (1) BRPI0909818A2 (enExample)
CA (1) CA2719115A1 (enExample)
IL (1) IL207792A0 (enExample)
MX (1) MX2010009844A (enExample)
RU (1) RU2010135831A (enExample)
TW (1) TW200950783A (enExample)
WO (1) WO2009109844A1 (enExample)
ZA (1) ZA201005905B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010082855A1 (en) * 2009-01-15 2010-07-22 Zaklady Farmaceutyczne Polpharma Sa Pharmaceutical compositions comprising ziprasidone free base or ziprasidone hydrochloride and the method for their preparation
US9510148B2 (en) * 2009-03-03 2016-11-29 Mobilitie, Llc System and method for wireless communication to permit audience participation
EP2991650A4 (en) * 2013-05-03 2017-01-25 Syndax Pharmaceuticals Inc. Methods for the treatment of cancer
TW201602108A (zh) 2013-07-30 2016-01-16 吉李德康乃狄克公司 脾酪胺酸激酶（Ｓｙｋ）抑制劑之多晶型
NZ715745A (en) 2013-07-30 2017-06-30 Gilead Connecticut Inc Formulation of syk inhibitors
EP3076951B1 (en) * 2013-12-05 2020-09-30 Celal Albayrak Process for the production of drug formulations for oral administration
TWI662037B (zh) 2013-12-23 2019-06-11 美商基利科學股份有限公司 脾酪胺酸激酶抑制劑
US10474345B2 (en) * 2014-04-04 2019-11-12 Shawn SHEY User interfaces and methods for displaying content
EP3193844A1 (en) * 2014-09-19 2017-07-26 The Procter and Gamble Company Process for making a core with an active coating
JP6796083B2 (ja) 2015-06-09 2020-12-02 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌ Ｂｅｌｇｉｕｍ ＮＶ カプセル中の薬剤の噴霧乾燥ディスパーションからの迅速な溶解を達成するための製剤
US11154510B2 (en) 2015-06-11 2021-10-26 Alrise Biosystems Gmbh Process for the preparation of drug loaded microparticles
CN107714669A (zh) * 2016-08-11 2018-02-23 广东东阳光药业有限公司 齐拉西酮缓释剂及其制备方法
EP3672974A1 (en) 2017-08-25 2020-07-01 Gilead Sciences, Inc. Polymorphs of syk inhibitors
JP2022521413A (ja) 2019-02-22 2022-04-07 クロノス バイオ インコーポレイテッド Ｓｙｋ阻害剤としての縮合ピラジンの固体形態

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2450748A1 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
MXPA06002455A (es) * 2003-09-02 2006-08-31 Pfizer Prod Inc Formas de dosificacion de liberacion sostenida de ziprasidona.
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
EP1703898A2 (en) * 2003-12-31 2006-09-27 Alpharma, Inc. Ziprasidone formulations
EP1753400A4 (en) * 2004-06-11 2012-11-28 Reddys Lab Ltd Dr PHARMACEUTICAL FOR ZIPRASIDONE
SG162811A1 (en) * 2005-06-20 2010-07-29 Elan Pharma Int Ltd Nanoparticulate and controlled release compositions comprising aryl- heterocyclic compounds

Also Published As

Publication number Publication date
AR070964A1 (es) 2010-05-19
AU2009220925A1 (en) 2009-09-11
JP2009215293A (ja) 2009-09-24
WO2009109844A1 (en) 2009-09-11
BRPI0909818A2 (pt) 2015-10-06
CN102014910A (zh) 2011-04-13
IL207792A0 (en) 2010-12-30
CA2719115A1 (en) 2009-09-11
EP2280711A1 (en) 2011-02-09
TW200950783A (en) 2009-12-16
US20110002989A1 (en) 2011-01-06
KR20100131477A (ko) 2010-12-15
MX2010009844A (es) 2010-09-30
RU2010135831A (ru) 2012-04-20

Similar Documents

Publication Publication Date Title
ZA201005905B (en) Methods,dosage forms,and kits for administering ziprasidone without food
IL205360A0 (en) Methods, kits, and compositions for administering pharmaceutical compounds
SI2376537T1 (sl) Humana protitelesa zoper humani faktor tkiva
AP2011005943A0 (en) Atropisomers of 2-purinyl-3-tolylquinazolinone derivatives and methods of use.
AP2012006064A0 (en) Compounds and methods for treating influenza.
PL2245037T3 (pl) Nowe związki i sposoby leczenia
EP2395938A4 (en) Components for use with implants, and related methods
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
AP2010005379A0 (en) Anti-TRKA antibodies and derivatives.
AP2011005824A0 (en) Methods for treating acute myocardial infarctions and associated disorders.
AP2011005681A0 (en) Methods and formulations for treating chronic liver disease.
IL210514A0 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
GB0810850D0 (en) Tobacco treatment
ZA201008387B (en) Azacarboline derivatives,preparation thereof,and therapeutic use thereof as kinase inhibitors
GB0807018D0 (en) Antibodies and treatment
IL216388A0 (en) New compounds, pharmaceutical composition and methods relating thereto
ZA201008589B (en) Medicament dispenser and method
IL219888A0 (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
PL2293670T3 (pl) Kompozycje i sposoby leczenia grzybicy paznokci
AP2012006124A0 (en) Methods and compositions for treating thyroid-related medical conditions with reduced folates.
IL207629A0 (en) Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof
GB0803054D0 (en) Medicament
SI2421864T1 (sl) 1-pirazolo(4,3-c)izokinolinski derivati, njihova priprava in njihova terapevtska uporaba
ZA201101547B (en) Anti-extended type i glycosphingolipid antibody,derivatives thereof and use
EP2350212A4 (en) POLYAMINO-ACETONITRILES, PROCESSES FOR PREPARING THEM AND USE THEREOF